STOCK TITAN

Maravai Lifesciences (MRVI) director reports 92,586-share stock gift

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Maravai Lifesciences Holdings director Gregory T. Lucier reported gifting 92,586 shares of Class A common stock. On June 9, 2026, he made two bona fide gift transfers of 46,293 shares each at $0.00 per share.

Following these gifts, Lucier holds 155,123 shares directly and 156,077 shares indirectly through a family partnership. According to the disclosure, the family partnership is managed by his spouse, and Lucier disclaims beneficial ownership of those partnership-held shares except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider LUCIER GREGORY T
Role Director
Type Security Shares Price Value
Gift Class A Common Stock 46,293 $0.00 $0.00
Gift Class A Common Stock 46,293 $0.00 $0.00
Holdings After Transaction: Class A Common Stock — 155,123 shares (Direct); Class A Common Stock — 156,077 shares (Indirect, By Family Partnership)
Footnotes (1)
  1. F1. Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.
Total shares gifted 92,586 shares Bona fide gifts of Class A common stock on June 9, 2026
Shares gifted per transaction 46,293 shares Each of two gift transactions of Class A common stock
Direct holdings after transaction 155,123 shares Class A common stock held directly following gifts
Indirect holdings after transaction 156,077 shares Class A common stock held indirectly via family partnership after gifts
Gift transaction price $0.00 per share Reported price for both bona fide gift transfers
bona fide gift financial
"Each transaction is coded as a bona fide gift of Class A common stock."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
pecuniary interest financial
"The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest."
Section 16 regulatory
"Not an admission that the reporting person is the beneficial owner for purposes of Section 16 of the Exchange Act."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
dispositive power financial
"The reporting person's spouse, as general partner, may have voting and dispositive power over all such shares."
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did MRVI director Gregory Lucier report?

Gregory T. Lucier reported bona fide gift transfers of 92,586 shares of Maravai Lifesciences Class A common stock. The gifts were recorded as two separate 46,293-share transactions with a reported price of $0.00 per share, indicating non-cash transfers.

How many MRVI shares did Gregory Lucier gift on June 9, 2026?

He gifted a total of 92,586 Class A common shares on June 9, 2026. This was executed as two equal transactions of 46,293 shares each, classified as bona fide gifts with no sale proceeds reported.

What are Gregory Lucier’s MRVI holdings after the reported gifts?

After the gifts, Gregory Lucier holds 155,123 Maravai Lifesciences shares directly and 156,077 shares indirectly via a family partnership. These post-transaction balances are disclosed separately for direct and indirect ownership in the Form 4 filing.

How are the indirect MRVI shares held for Gregory Lucier?

The indirect shares are held through a family partnership whose partners include a trust benefiting Gregory Lucier. His spouse serves as general partner with potential voting and dispositive power, while Lucier disclaims beneficial ownership except for his pecuniary interest.

Does the MRVI Form 4 show any insider stock sales by Gregory Lucier?

The Form 4 reports bona fide gifts, not open-market sales, by Gregory Lucier. Both transactions are coded as “G” for gift at a reported price of $0.00 per share, indicating non-cash dispositions rather than sales for proceeds.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LUCIER GREGORY T

(Last)(First)(Middle)
C/O MARAVAI LIFESCIENCES HOLDINGS, INC.
10770 WATERIDGE CIRCLE, SUITE 200

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/09/2026G46,293(1)D$0155,123D
Class A Common Stock06/09/2026G46,293(1)A$0156,077IBy Family Partnership
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.
Remarks:
/s/ Kurt Oreshack, by power of attorney for Gregory T. Lucier06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)